Skip to main content

Table 5 Adverse effects reported/observed

From: Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

AE

Grade 1–2

Grade3 or more

Total N (%)

Nausea

10 (33.3%)

0 (−)

10 (33.3%)

Vomiting

2 (6.7%)

0 (−)

2 (6.7%)

Poor appetite

11 (36.7%)

0 (−)

11 (36.7%)

Diarrhea

2 (6.7%)

1 (3.3%)

3 (10.0%)

Hepatic injury

1 (3.3%)

0 (−)

1 (3.3%)

Renal injury

2 (6.7%)

0 (−)

2 (6.7%)

Leucopenia

5 (16.7%)

0 (−)

5 (16.7%)

Thrombocytopenia

6 (20.0%)

0 (−)

6 (20.0%)

Fatigue

14 (46.7%)

0 (−)

14 (46.7%)

Myalgia

2 (6.7%)

0 (−)

2 (6.7%)

Abdominal pain

11 (36.7%)

0 (−)

11 (36.7%)